looking better and better each week as the SP continues to be proportional to key milestones being met. I personally expect the current trajectory to continue and sharpen as time goes on particularly closer to the US listing date.
We all know that the military bill (113th congress) found last OCTOBER is now signed into law and nick is currently working with the DOD to submit the report on extending supply to all military sections. This time is up in June and i would dare say large contracts will be announced there after.
Now i want to bring peoples attention to a very large commercial sector bill S2811 that we know has been introduced by senator schumer. I suggests investors read this in full particularly the "text " sub heading which explains the following.
1. chemical names of the 10 proposed banned substances.
2.Explains there will be a chronic hazard advisory panel initiated within 180 days of the bill being passed.
3. Explains the criteria the panel have to study and report on.
There are many more this is just to name a few and there is time limits on the study as the US government wants this pushed through. This is a great and very interesting read and to be honest is see manufactures making the shift well before the legislation is finished. I have read other articles about the bill and they all say this will be passed this year in 114th congress.
Just remember alexium's plan of "being a significant partner to the US government" well this is well and truly one section that defines that statement and you cant say the 6 meetings nick has attended with the consumer protection agency has not already given alexium a very favorable look in. My belief is the EAS ,investment banks and government connections have the story already written and will slowly but surely release it over the next 12/18 months.
For progress tracking purposes please use the link below as we did when we were tracking the military bill.
To prohibit the distribution in commerce of children's products and
upholstered furniture containing certain flame retardants, and for other purposes.
Be it enacted by the Senate and House of Representatives of the
United States of America in Congress assembled,
SECTION 1. SHORT TITLE.
This Act may be cited as the ``Children and Firefighters Protection
Act of 2014''.
SEC. 2. PROHIBITION ON SALE OF CERTAIN PRODUCTS CONTAINING SPECIFIED FLAME RETARDANTS.
(a) Definitions.--In this section, the terms ``children's
product'', ``consumer product'', ``distribute in commerce'',
``distributor'', ``import'', ``manufacturer'', ``retailer'', and
``United States'' have the meanings given such terms in section 3(a) of
the Consumer Product Safety Act (15 U.S.C. 2052(a)). (b) Prohibition.--It shall be unlawful for any manufacturer,
distributor, or retailer to sell, offer for sale, manufacture for sale,
distribute in commerce, or import into the United States any children's
product or upholstered furniture that contains a flame retardant
specified in subsection (c) that exceeds 1,000 parts per million total
chemical content by weight for any part of the product or furniture. (c) Specified Flame Retardants.--The flame retardants specified in
this subsection are the following: (1) Tris(1,3-dichloro-2-propyl)phosphate (TDCPP) (chemical abstracts service number 13674-87-8). (2) Tris(2-chloroethyl)phosphate (TCEP) (chemical abstracts service number 115-1496-8). (3) Tetrabromobisphenol A (TBBPA) (chemical abstracts service number 79-94-7). (4) Decabromodiphenyl ether (chemical abstracts service number 1163-19-5). (5) Antimony trioxide (chemical abstracts service number 1309-64-4). (6) Hexabromocyclododecane (HBCD) (chemical abstracts service number 25637-99-4). (7) Bis(2-Ethylhexyl)-3,4,5,6-tetrabromophthalate (TBPH) (chemical abstract service number 26040-51-7). (8) 2-EthylhexYl-2,3,4,5-tetrabromobenzoate (TBB) (chemical abstract service number 183658-27-7). (9) Chlorinated paraffins (chemical abstract services number 85535-84-8). (10) Tris (1-chloro-2-propyl) phosphate (TCPP) (chemical abstract service number 13674-84-5). (11) Such other chemical flame retardants as the Commission may specify by rule under subsection (d)(5). (d) Chronic Hazard Advisory Panel.-- (1) Appointment.--Not later than 180 days after the date of the enactment of this Act, the Commission shall appoint a chronic hazard advisory panel pursuant to the procedures of section 28 of the Consumer Product Safety Act (15 U.S.C. 2077) to study the effects on human health of all chemical flame retardants as used in children's products or upholstered furniture. (2) Examination.-- (A) In general.--The panel shall, not later than 540 days after the date on which the panel is appointed under paragraph (1), complete an examination of the potential hazards and exposures for the full range of chemical flame retardants that may be used in children's products or upholstered furniture to meet applicable fire safety standards and shall-- (i) examine potential health effects of the chemical flame retardants, including-- (I) developmental toxicity; (II) carcinogenicity, genetic damage, or reproductive toxicity; (III) endocrine disruption; (IV) toxicity related to the nervous system, immune system, or organs or cause other systemic toxicity; and (V) whether they are-- (aa) persistent, bioaccumulative, and toxic; or (bb) very persistent and very bioaccumulative; (ii) consider the potential health effects of such chemical flame retardants, both in isolation and in combination with other flame retardants; (iii) examine biomonitoring studies that document existing levels and likely future levels of chemical flame retardants in children, pregnant women, firefighters (including combustion by-products of chemical flame retardants), and others; (iv) examine data and analysis regarding the chemical flame retardants in household dust, indoor air, or elsewhere in the home environment; (v) consider the cumulative effects of total exposure to flame retardants, both from children's products, upholstered furniture, and from other sources, such as food, commercial furniture, building insulation, and electronics; (vi) review all relevant data, including the most recent, best-available, peer-reviewed, scientific studies of these chemical flame retardants that employ objective data collection practices or employ other objective methods; (vii) consider the amounts of chemical flame retardants used in consumer products and the total volumes manufactured for use; and (viii) consider possible similar health effects of chemical flame retardants used in children's products or upholstered furniture. (3) Do novo.--The panel's examinations pursuant to this subsection shall be conducted de novo. The findings and conclusions of any previous chronic hazard advisory panel on chemical flame retardants and other studies conducted by the Commission shall be reviewed by the panel but shall not be considered determinative. (4) Report.--Not later than 180 days after completing its examination, the panel appointed under paragraph (1) shall submit to the Commission a report on the results of the examination conducted under this section and shall make recommendations to the Commission regarding any chemical flame retardants (or combinations of chemical flame retardants) in addition to those identified in paragraphs (1) through (10) of subsection (c) that the panel determines should be prohibited under subsection (b). (5) Specification of additional chemical flame retardants.--Not later than 180 days after receiving the report of the panel under paragraph (4), the Commission shall-- (A) evaluate the findings of the chronic hazard advisory panel regarding the examination carried out under paragraph (2); (B) evaluate the recommendations submitted by the chronic hazard advisory panel under paragraph (4); and (C) promulgate a final rule, based on the evaluations carried out under subparagraphs (A) and (B) of this paragraph, that specifies such chemical flame retardants that are not listed in paragraphs (1) through (10) of subsection (c) as the Commission determines that the presence of such chemical flame retardant in any part of a children's product or upholstered furniture may cause substantial personal injury or substantial illness, including-- (i) developmental or learning disabilities; (ii) cancer; (iii) endocrine disruption; (iv) reproductive harm; or (v) damage to the nervous system, immune system, or organs or cause other systemic toxicity. (e) Treatment of Violation.--A violation of subsection (b) shall be
treated as a violation of section 19(a)(1) of the Consumer Product
Safety Act (15 U.S.C. 2068(a)(1)). (f) Product Certification and Labeling.--A product subject to
subsection (b) of this section shall not be subject to section 14(a)(2)
of the Consumer Product Safety Act (15 U.S.C. 2063(a)(2)) with respect
to testing for compliance with the requirements of this section. (g) Rulemaking.-- (1) In general.--The Consumer Product Safety Commission shall promulgate rules to carry out this section in accordance with section 553 of title 5, United States Code. (2) Exemption from certain requirements.--The requirements of sections 7 and 9 of the Consumer Product Safety Act (15 U.S.C. 2056 and 2058) shall not apply to a rulemaking under this section. (h) Relation to State Law.--This section shall not annul, alter, or
affect a provision of law of a State relating to the presence of a
chemical flame retardant in a children's product or upholstered
furniture except to the extent that such provision of law is
inconsistent with a provision of this section, and then only to the
extent of the inconsistency. For purposes of this section, a provision
of law of a State is not inconsistent with the provisions of this
section if the protection such provision of law affords any person is
greater than the protection provided under this section. (i) Effective Date.-- (1) In general.--This Act shall take effect on the date of the enactment of this Act, except subsection (b) shall take effect on the date that is 1 year after the date of the enactment of this Act. (2) Applicability.--Subsection (b) shall apply with respect to children's products and upholstered furniture manufactured after the date that is 1 year after the date of the enactment of this Act.
AJX Price at posting:
77.5¢ Sentiment: Buy Disclosure: Held
(20min delay)